Literature DB >> 2173354

Decreased density of benzodiazepine receptors in lymphocytes of anxious patients: reversal after chronic diazepam treatment.

C Ferrarese1, I Appollonio, M Frigo, M Perego, R Piolti, M Trabucchi, L Frattola.   

Abstract

Peripheral-type benzodiazepine receptors were measured in human circulating lymphocytes using 3H-PK 11195 as specific ligand. In a group of outpatients with anxiety disorders a significant decrease of receptor density (-37%) was found compared with age-matched controls. In these patients long-term diazepam treatment restored binding density to normal levels: the effect persisted after drug withdrawal. Acute i.v. diazepam administration did not change receptor density. The observed receptor changes could reflect a down-regulation phenomenon and indicate that lymphocyte function reflect central nervous events.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173354     DOI: 10.1111/j.1600-0447.1990.tb01376.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  8 in total

1.  Acute noise stress in rats increases the levels of diazepam binding inhibitor (DBI) in hippocampus and adrenal gland.

Authors:  C Ferrarese; T Mennini; N Pecora; M Gobbi; I Appollonio; P Bernasconi; M Frigo; C Regondi; C Pierpaoli; L Frattola
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Peripheral-type benzodiazepine receptor binding sites in platelets of patients with panic disorder associated to separation anxiety symptoms.

Authors:  Stefano Pini; Claudia Martini; Marianna Abelli; Matteo Muti; Camilla Gesi; Marina Montali; Beatrice Chelli; Antonio Lucacchini; Giovanni B Cassano
Journal:  Psychopharmacology (Berl)       Date:  2005-10-14       Impact factor: 4.530

3.  Comparison of [(11)C]-(R)-PK 11195 and [(11)C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker.

Authors:  William C Kreisl; Masahiro Fujita; Yota Fujimura; Nobuyo Kimura; Kimberly J Jenko; Pavitra Kannan; Jinsoo Hong; Cheryl L Morse; Sami S Zoghbi; Robert L Gladding; Steven Jacobson; Unsong Oh; Victor W Pike; Robert B Innis
Journal:  Neuroimage       Date:  2009-12-04       Impact factor: 6.556

4.  An analysis of peripheral type benzodiazepine receptors on blood mononuclear cells during high dose steroid treatment of multiple sclerosis.

Authors:  P Ferrero; P Rocca; P Benna; C De Leo; E Montalenti; L Ravizza; B Bergamasco
Journal:  Ital J Neurol Sci       Date:  1992-11

5.  Modifications of diazepam binding inhibitor and peripheral benzodiazepine receptors in the lymphocytes of epileptic patients.

Authors:  C Ferrarese; M Perego; C Marzorati; G Bianchi; M Frigo; N Pecora; R Riva; G Moretti; L Frattola
Journal:  Ital J Neurol Sci       Date:  1996-04

6.  The Potential Use of Peripheral Blood Mononuclear Cells as Biomarkers for Treatment Response and Outcome Prediction in Psychiatry: A Systematic Review.

Authors:  Jobbe Goossens; Manuel Morrens; Violette Coppens
Journal:  Mol Diagn Ther       Date:  2021-05-12       Impact factor: 4.074

7.  Neurosteroids as neuromodulators in the treatment of anxiety disorders.

Authors:  Patrizia Longone; Flavia di Michele; Elisa D'Agati; Elena Romeo; Augusto Pasini; Rainer Rupprecht
Journal:  Front Endocrinol (Lausanne)       Date:  2011-10-19       Impact factor: 5.555

8.  Changes in peripheral benzodiazepine receptors in patients with bipolar disorder.

Authors:  Donatella Marazziti; Bernardo Dell'Osso; Stefano Baroni; Irene Masala; Elena Di Nasso; Gino Giannaccini; Liliana Dell'Osso
Journal:  Neuropsychiatr Dis Treat       Date:  2005-06       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.